ArticleCancers2022

ACY1 Downregulation Enhances the Radiosensitivity of Cetuximab-Resistant Colorectal Cancer by Inactivating the Wnt/β-Catenin Signaling Pathway.

Wulin Shan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.